Back
CRISPR Therapeutics AG Stock Predictions
Sponsored
CRSP
Sponsored
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
52.16
Seasonality Move:
27.39%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeCRISPR Therapeutics AG Stock Forecast
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 40.4% based on the past 7 years of stock performance.
- CRISPR Therapeutics AG has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
-
Is CRISPR Therapeutics AG Stock Undervalued?
The current CRISPR Therapeutics AG [CRSP] share price is $53.29. The Score for CRSP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
- Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 40.4% based on the past 7 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
- CRISPR Therapeutics AG has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
91.10
52-Week Low:
37.55
Prediction Charts
Market Cap:
4.52B
Price in USD:
53.29
Volume:
1.52M
Beta:
2.03
Technical Analysis
SMA50:
66.20
SMA100:
67.00
SMA200:
59.36
52-Wk Change:
-4.77%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?
Yes, CRISPR Therapeutics AG is a publicly traded company. -
What is the CRISPR Therapeutics AG stock quote today?
The CRISPR Therapeutics AG stock price is 53.29 USD today. -
How to buy CRISPR Therapeutics AG stock online?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-19 | 56.16 | 55.09 | 57.50 | 54.28 |
Apr-22 | 55.40 | 55.68 | 56.93 | 54.37 |
Apr-23 | 55.93 | 56.41 | 58.68 | 55.56 |
Apr-24 | 56.79 | 55.65 | 57.78 | 55.50 |
Apr-25 | 53.98 | 53.73 | 54.15 | 52.75 |
Apr-26 | 54.21 | 53.91 | 54.94 | 52.81 |
Apr-29 | 54.09 | 54.83 | 55.62 | 54.00 |
Apr-30 | 53.90 | 52.99 | 54.44 | 52.73 |
May-1 | 53.16 | 53.79 | 55.97 | 52.74 |
May-2 | 54.48 | 55.11 | 55.34 | 53.99 |
May-3 | 56.70 | 55.89 | 58.45 | 55.57 |
May-6 | 56.35 | 57.08 | 57.42 | 55.82 |
May-7 | 57.00 | 55.56 | 57.10 | 55.27 |
May-8 | 54.00 | 53.29 | 54.50 | 52.62 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.17 per share, a decrease this year of $2.67 per share, and an increase next year of $1.62 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.